THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Udho Thadani to Myocardial Infarction

This is a "connection" page, showing publications Udho Thadani has written about Myocardial Infarction.
Connection Strength

3.341
  1. Trans fatty acids linked to myocardial infarction and stroke: What is the evidence? Trends Cardiovasc Med. 2019 07; 29(5):306-310.
    View in: PubMed
    Score: 0.504
  2. Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction. Evid Based Med. 2017 12; 22(6):224.
    View in: PubMed
    Score: 0.475
  3. Routine invasive strategies compared with conservative strategies do not lower the all-cause mortality in patients with non-ST elevation myocardial infarction and unstable angina. Evid Based Med. 2017 10; 22(5):190.
    View in: PubMed
    Score: 0.466
  4. Invasive strategy in acute coronary syndrome. Lancet. 2016 Jun 18; 387(10037):2503-4.
    View in: PubMed
    Score: 0.431
  5. Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. Cardiology. 2012; 123(2):91-3.
    View in: PubMed
    Score: 0.333
  6. Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients. Am J Cardiol. 2009 Jun 15; 103(12):1687-93.
    View in: PubMed
    Score: 0.263
  7. Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction. Expert Opin Drug Saf. 2007 Jul; 6(4):385-96.
    View in: PubMed
    Score: 0.232
  8. Secondary preventive potential of nitrates in ischaemic heart disease. Eur Heart J. 1996 Dec; 17 Suppl F:30-6.
    View in: PubMed
    Score: 0.111
  9. Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States. Clin Cardiol. 2016 Jan; 39(1):9-18.
    View in: PubMed
    Score: 0.104
  10. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Am J Med Sci. 2011 Jan; 341(1):1-9.
    View in: PubMed
    Score: 0.074
  11. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2008 Feb; 31(2):353-60.
    View in: PubMed
    Score: 0.059
  12. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84.
    View in: PubMed
    Score: 0.054
  13. Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction. Clin Pharmacokinet. 2002; 41(6):445-52.
    View in: PubMed
    Score: 0.040
  14. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation. 1998 Nov 17; 98(20):2117-25.
    View in: PubMed
    Score: 0.032
  15. Choosing the most appropriate treatment for stable angina. Safety considerations. Drug Saf. 1998 Jul; 19(1):23-44.
    View in: PubMed
    Score: 0.031
  16. Oral nitrates: more than symptomatic therapy in coronary artery disease? Cardiovasc Drugs Ther. 1997 May; 11 Suppl 1:213-8.
    View in: PubMed
    Score: 0.029
  17. Nitrates for unstable angina. Cardiovasc Drugs Ther. 1994 Oct; 8(5):719-26.
    View in: PubMed
    Score: 0.024
  18. Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group. Am J Cardiol. 1993 Feb 15; 71(5):386-92.
    View in: PubMed
    Score: 0.021
  19. Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction. Am J Cardiol. 1992 May 01; 69(14):1120-7.
    View in: PubMed
    Score: 0.020
  20. Pericarditis after acute myocardial infarction. Br Med J. 1971 Apr 17; 2(5754):135-7.
    View in: PubMed
    Score: 0.019
  21. Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible? Circulation. 1980 Apr; 61(4):744-50.
    View in: PubMed
    Score: 0.009
  22. Plasma cortisol, urinary 17-hydroxycorticoids, and urinary vanilyl mandelic acid after acute myocardial infarction. Br Heart J. 1972 Oct; 34(10):992-7.
    View in: PubMed
    Score: 0.005
  23. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial. Br Med J. 1971 Sep 18; 3(5776):668-70.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES